$21.82
+0.38 (+1.77%)
Open$21.40
Previous Close$21.44
Day High$22.25
Day Low$21.01
52W High$23.24
52W Low$10.96
Volume—
Avg Volume806.7K
Market Cap1.09B
P/E Ratio—
EPS$-0.39
SectorBiotechnology
Analyst Ratings
Buy
14 analysts
Price Target
+128.3% upside
Current
$21.82
$21.82
Target
$49.81
$49.81
$29.15
$49.81 avg
$64.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 364.15M | 344.58M | 329.37M |
| Net Income | -20,472,001 | -17,434,520 | -60,795,749 |
| Profit Margin | -5.6% | -5.3% | -18.5% |
| EBITDA | -26,516,018 | -23,836,314 | -79,903,104 |
| Free Cash Flow | — | — | -60,969,564 |
| Rev Growth | +5.7% | +5.7% | -9.3% |
| Debt/Equity | — | — | 0.76 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |